Literature DB >> 21940418

Southern Tick-Associated Rash Illness (STARI) in the North: STARI following a tick bite in Long Island, New York.

Henry M Feder1, Diane M Hoss, Lawrence Zemel, Sam R Telford, Feliciano Dias, Gary P Wormser.   

Abstract

The most common clinical manifestation of Lyme disease is the characteristic rash, erythema migrans (EM). In the 1980s EM-like eruptions were reported in Missouri and other southeastern states. The EM-like eruptions, which were of unknown etiology, often followed the bite of the Lone Star tick (Amblyomma americanum) and the rash is called STARI (southern tick-associated rash illness). Although the Lone Star tick is found in the Lyme disease-endemic areas of New England and Mid-Atlantic regions of the United States, STARI has been reported only once from the Northeast and Mid-Atlantic regions. We report a child from Connecticut who visited Long Island, New York, and developed a rash that was thought to be EM. Because the patient failed to respond to antibiotics used to treat Lyme disease, an investigation ensued, and the diagnosis of STARI was established.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940418     DOI: 10.1093/cid/cir553

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Detection of a Borrelia species in questing Gulf Coast ticks, Amblyomma maculatum.

Authors:  Jung Keun Lee; Whitney Crow Smith; Chelsea McIntosh; Flavia Girao Ferrari; Brittany Moore-Henderson; Andrea Varela-Stokes
Journal:  Ticks Tick Borne Dis       Date:  2014-04-24       Impact factor: 3.744

2.  Metabolic differentiation of early Lyme disease from southern tick-associated rash illness (STARI).

Authors:  Claudia R Molins; Laura V Ashton; Gary P Wormser; Barbara G Andre; Ann M Hess; Mark J Delorey; Mark A Pilgard; Barbara J Johnson; Kristofor Webb; M Nurul Islam; Adoracion Pegalajar-Jurado; Irida Molla; Mollie W Jewett; John T Belisle
Journal:  Sci Transl Med       Date:  2017-08-16       Impact factor: 17.956

3.  Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient.

Authors:  Joseph L Gugliotta; Heidi K Goethert; Victor P Berardi; Sam R Telford
Journal:  N Engl J Med       Date:  2013-01-17       Impact factor: 91.245

Review 4.  Borrelia miyamotoi Disease: Neither Lyme Disease Nor Relapsing Fever.

Authors:  Sam R Telford; Heidi K Goethert; Philip J Molloy; Victor P Berardi; Hanumara Ram Chowdri; Joseph L Gugliotta; Timothy J Lepore
Journal:  Clin Lab Med       Date:  2015-09-18       Impact factor: 1.935

5.  Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study.

Authors:  Paul M Lantos; R Jory Brinkerhoff; Gary P Wormser; Robert Clemen
Journal:  Vector Borne Zoonotic Dis       Date:  2013-10-09       Impact factor: 2.133

Review 6.  Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.

Authors:  Edgar Sanchez; Edouard Vannier; Gary P Wormser; Linden T Hu
Journal:  JAMA       Date:  2016-04-26       Impact factor: 56.272

Review 7.  Pathogenesis of Relapsing Fever.

Authors:  Job Lopez; Joppe W Hovius; Sven Bergström
Journal:  Curr Issues Mol Biol       Date:  2020-12-29       Impact factor: 2.081

Review 8.  Relapsing Fevers: Neglected Tick-Borne Diseases.

Authors:  Emilie Talagrand-Reboul; Pierre H Boyer; Sven Bergström; Laurence Vial; Nathalie Boulanger
Journal:  Front Cell Infect Microbiol       Date:  2018-04-04       Impact factor: 5.293

9.  Identification of Urine Metabolites as Biomarkers of Early Lyme Disease.

Authors:  Adoracion Pegalajar-Jurado; Bryna L Fitzgerald; M Nurul Islam; John T Belisle; Gary P Wormser; Kathlene S Waller; Laura V Ashton; Kristofor J Webb; Mark J Delorey; Rebecca J Clark; Claudia R Molins
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

10.  The growing importance of lone star ticks in a Lyme disease endemic county: Passive tick surveillance in Monmouth County, NJ, 2006 - 2016.

Authors:  Robert A Jordan; Andrea Egizi
Journal:  PLoS One       Date:  2019-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.